22 research outputs found
PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS.
Background: The current study aimed to evaluate the role of carnitine in combination with vitamin E in protection
against myocardial infarction induced by isoproterenol (ISO) in rats.
Materials and Methods: Rats were grouped into 5 (each 10 rats): Group I. Control fed a standard diet. Group III: Rats
were injected with vitamin E (100 IU/kg bw, i.p) daily. Group IV: Rats were given carnitine (20 mg/kg bw, i.p) daily
.Group V: Rats were injected with both vitamin E (100 IU/kg bw, i.p) and carnitine (20 mg/kg bw, i.p) daily. On 7th,
8th, and 9th day, rats in groups (II-V) were injection i.p with ISO (55mg/kg b.w for successive three days). The
treatment with carnitine and vitamin E were continuous for 21 days.
Results: Canirine combined with vitamin E significantly increased coronary flow (CF) (
Therapeutic effect of combination vitamin D3 and siponimod on remyelination and modulate microglia activation in cuprizone mouse model of multiple sclerosis
Stimulation of remyelination is critical for the treatment of multiple sclerosis (MS) to alleviate symptoms and protect the myelin sheath from further damage. The current study aimed to investigate the possible therapeutic effects of combining vitamin D3 (Vit D3) and siponimod (Sipo) on enhancing remyelination and modulating microglia phenotypes in the cuprizone (CPZ) demyelination mouse model. The study was divided into two stages; demyelination (first 5 weeks) and remyelination (last 4 weeks). In the first 5 weeks, 85 mice were randomly divided into two groups, control (n = 20, standard rodent chow) and CPZ (n = 65, 0.3% CPZ mixed with chow for 6 weeks, followed by 3 weeks of standard rodent chow). At week 5, the CPZ group was re-divided into four groups (n = 14) for remyelination stages; untreated CPZ (0.2 ml of CMC orally), CPZ+Vit D3 (800 IU/kg Vit D3 orally), CPZ+Sipo (1.5 mg/kg Sipo orally), and CPZ+Vit D3 (800 IU/kg Vit D3) + Sipo (1.5 mg/kg Sipo orally). Various behavioral tasks were performed to evaluate motor performance. Luxol Fast Blue (LFB) staining, the expression level of myelin basic protein (MBP), and M1/M2 microglia phenotype genes were assessed in the corpus callosum (CC). The results showed that the combination of Vit D3 and Sipo improved behavioral deficits, significantly promoted remyelination, and modulated expression levels of microglia phenotype genes in the CC at early and late remyelination stages. These results demonstrate for the first time that a combination of Vit D3 and Sipo can improve the remyelination process in the cuprizone (CPZ) mouse model by attenuating the M1 microglia phenotype. This may help to improve the treatment of MS patients
Analysis of SNPs of MC4R , GNB3 and FTO gene polymorphism in obese Saudi subjects
Background: The goal of this study was to analyze the association between the FTO rs17817449 (G>T), G protein beta3 subunit (GNB3) C825T and Melanocortin 4 receptor (MC4R) A822G single nucleotide olymorphism (SNP) with obesity in Saudi subjects.Methods: The subjects were divided into 2 groups according to BMI: Obese (BMI> 29.9) and non- obese control (BMI<24.9). Genotyping of the target genes were determined by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism analysis (RFLP).Results: We demonstrated the association of the FTO genotype TT with increased weight, BMI and leptin levels in both males and females. However, there was no association of genotype TT with fasting blood glucose, triglycerides and cholesterol levels. Regarding GNB3 rs5443 polymorphism, the likelihood of obesity was linked to the TT genotype which was also associated with increased leptin levels. On the other hand, the SNP of MC4R A822G did not exhibit any significant association with obesity among studied subjects and showed only the presence of homozygous AA genotype.Conclusion: The polymorphism of FTO gene rs17817449 and GNB3 gene rs5443 (C825T) may be a genetic determinant of obesity in Saudi population whereas impact of MC4R Asn274Ser change could not be detected.Keywords: Obesity, FTO gene-polymorphism
Changes in erythrocyte ATPase activity under different pathological conditions
Background: Studies have shown that Na+-K+ ATPase activity was altered in disrupted red blood cell membranes and this enzyme is believed to be the site of active transport of Na+ and K+ in intact red blood cells. The enzyme is often referred to as Na+- K+ pump because it pumps Na+ out and K+ into the cell against gradients with the concomitant hydrolysis of intracellular ATP.Objective: The aim of this study was to find out the possibility of using Na+-K+-ATPase activity as a biomarker for the diagnosis of individuals with different physiological conditions.Materials and methods: The activity of Na+-K+ ATPase was determined in blood samples collected from different pathological and physiological conditions such as pregnancy, smoking, diabetes and renal dysfunction compared with healthy subjects matched for age and sex.Results: The Na+-K+ ATPase activity in pregnancy (0.094 ± 0.0051 μM Pi/min. mg protein), smoking (0.064 ± 0.0011 μM), diabetes (0.047 μM 0.002 μM) and kidney disease (0.069 ± 0.0014 μM) was higher compared to the measurements in healthy individuals (0.0081 ± 0.0031 μM).Conclusion: Na+- K+ATPase specific activity is a biomarker for the diagnosis of individuals with different physiological diseases.Keywords: Na+-K+ATPase, red blood cell, pregnancy, smoking, diabetes, kidney diseases
Serum proteins C and S levels as early biomarkers for kidney dysfunction in hemophilic patients
Background: Hemophilia is an inherited genetic disease characterized by the inability to coagulate blood after injury. The rationale of the current study was to evaluate serum proteins S and C and correlate to kidney function test in hemophilic patients for early diagnosis of abnormality in renal function.Subjects and Methods: This study was conducted on 80 males subjects divided into four groups. Group I: Control: Healthy subjects. Group II: Renal dysfunction (serum Creatinine >2mg/dl): Group III: Hemophilic patients. Group IV: Hemophilic patients with renal disorder. Serum urea, creatinine, sodium, potassium, protein C and protein S level were determined. Resuts: Protein C and S levels showed a significant decrease in hemophilic/and with renal dysfunction (P < 0.001,p<0.001). The level of plasma protein C and S levels were positively correlated with increased urinary albumin (P < 0.01). Urinary albumin was increased about 15 folds in hemophilic patients with renal dysfunction and nephrotic patients as compared with the control group. The cut-off value in 90% patients at the hemophilic patients with renal dysfunction 70%. Positive correlations were observed between urinary albumin (r=0.66), and creatinine (r=0.73). Conclusion: These biomarkers showed good predictive values with regard to ROC-AUC (0.41 and 0.75 for Proteins C and S, respectively).Keywords: Hemophilia, renal dysfunction, protein C, protein S
POTENTIAL ADMINISTRATION OF LIPOIC ACID AND COENZYME Q AGAINST ADIPOGENSIS: TARGET FOR WEIGHT REDUCTION
Background: Body overweight and obesity were considered as a risk factor for many systemic diseases as diabetic
hypertension, cardiovascular diseases, and some cancers. The lipoic acid and Co Q are considered as coenzymes
needed for enhancement metabolic rate. The goal of this study is to evaluate the anti-obese effect of lipoic acid alone or
combined with Co-Q in rats.
Materials and Methods: Ninety male albino rats (100–150g) were used in this study, divided into six groups (15
each). Group I: Normal rats fed normal diet. Group II: Rats fed high fat diet (HFD). Group III: Rats fed HFD were
given lipoic acid (10 μg/kg b w /day) intra-gastric by stomach tube. Group IV: Rats fed HFD were given Co-Q (10 μg
/kg b.w/day) intra-gastric. Group V: Rats fed HFD were given lipoic acid (50 mg/kg b w /day) and Co-Q (10 μg /kg b.
w/day). Group VI: Rats were given orlistat intra-gastric (10 mg/kg b w/day) as positive control for 6 weeks. Serum was
subjected for determination of lipid profile, liver function tests atherogenic factor and lipoprotein lipase.
Results: It was found that treatment with lipoic acid or Co-Q or combined showed increase in the activity of
lipoprotein lipase
Serum proteins C and S levels as early biomarkers for kidney dysfunction in hemophilic patients
Background: Hemophilia is an inherited genetic disease characterized by
the inability to coagulate blood after injury. The rationale of the
current study was to evaluate serum proteins S and C and correlate to
kidney function test in hemophilic patients for early diagnosis of
abnormality in renal function. Subjects and Methods: This study was
conducted on 80 males subjects divided into four groups. Group I:
Control: Healthy subjects. Group II: Renal dysfunction (serum
Creatinine >2mg/dl): Group III: Hemophilic patients. Group IV:
Hemophilic patients with renal disorder. Serum urea, creatinine,
sodium, potassium, protein C and protein S level were determined.
Resuts: Protein C and S levels showed a significant decrease in
hemophilic/and with renal dysfunction (P < 0.001,p<0.001). The
level of plasma protein C and S levels were positively correlated with
increased urinary albumin (P < 0.01). Urinary albumin was increased
about 15 folds in hemophilic patients with renal dysfunction and
nephrotic patients as compared with the control group. The cut-off
value in 90% patients at the hemophilic patients with renal dysfunction
70%. Positive correlations were observed between urinary albumin
(r=0.66), and creatinine (r=0.73). Conclusion: These biomarkers showed
good predictive values with regard to ROC-AUC (0.41 and 0.75 for
Proteins C and S, respectively)
Ultrasonographic and biochemical assessments as early prediction of polycystic ovarian syndrome in obese women
Backgroud: Polycystic ovary syndrome (PCOS) is considered as a common
cause of hormonal disturbance and obesity. The diagnosis of PCOS was
done by different methods including clinical signs as anovulation,
hyperandrogenism, biochemical markers and ultrasounographic
investigation. This study investigated comparative outcomes of
ultrasonographic and biochemical markers for early prediction of PCOS
in obese women. Subjects and methods: Seventy-five patients were
clinically diagnosed with obese, PCOS and obese with PCOS and
twenty-five normal age matched subjects were enrolled as control.
Abdominal and transvaginal ultrasonographic for assessment of ovarian
properties. In addition, BMI, serum free testosterone,
dehydroepiandrosterone (DHEA), insulin, glycosylated hemoglobin (HbA1c)
and LDL-c levels were evaluated. Results: In obese patients with PCOs
(20%) ovaries revealed normal appearance in morphology while the rest
(80%) showed PCOs in the form of cysts of 2\u20138 mm in diameter
peripherally arranged around stroma. A significant elevation of free
testosterone, DHEA and insulin in obese with or without PCOS compared
with obese group (p<0.001). A positive correlation with hormonal
abnormalities of increased HA1c, LDL-c, free testosterone, DHEA and
insulin compared with obese only. Conclusion: According to our study
findings, ovarian morphology combined with biochemical markers is more
reliable for early prediction and diagnosis of PCOS for interpretation
and management